Finke JH - Search Results

1

Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70.

Chahlavi A, Rayman P, Richmond AL, Biswas K, Zhang R, Vogelbaum M, Tannenbaum C, Barnett G, Finke JH. Chahlavi A, et al. Among authors: finke jh. Cancer Res. 2005 Jun 15;65(12):5428-38. doi: 10.1158/0008-5472.CAN-04-4395. Cancer Res. 2005. PMID: 15958592

2

Effect of renal cell carcinomas on the development of type 1 T-cell responses.

Rayman P, Wesa AK, Richmond AL, Das T, Biswas K, Raval G, Storkus WJ, Tannenbaum C, Novick A, Bukowski R, Finke J. Rayman P, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6360S-6S. doi: 10.1158/1078-0432.CCR-050011. Clin Cancer Res. 2004. PMID: 15448031

3

Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells.

Kudo D, Rayman P, Horton C, Cathcart MK, Bukowski RM, Thornton M, Tannenbaum C, Finke JH. Kudo D, et al. Among authors: finke jh. Cancer Res. 2003 Apr 1;63(7):1676-83. Cancer Res. 2003. PMID: 12670922

4

Mechanisms of immune dysfunction in renal cell carcinoma.

Derweesh IH, Tannenbaum CS, Rayman PA, Finke JH. Derweesh IH, et al. Among authors: finke jh. Cancer Treat Res. 2003;116:29-51. doi: 10.1007/978-1-4615-0451-1_2. Cancer Treat Res. 2003. PMID: 14650824 Review. No abstract available.

5

GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction.

Biswas K, Richmond A, Rayman P, Biswas S, Thornton M, Sa G, Das T, Zhang R, Chahlavi A, Tannenbaum CS, Novick A, Bukowski R, Finke JH. Biswas K, et al. Among authors: finke jh. Cancer Res. 2006 Jul 1;66(13):6816-25. doi: 10.1158/0008-5472.CAN-06-0250. Cancer Res. 2006. PMID: 16818659

6

Renal cell carcinoma tumors induce T cell apoptosis through receptor-dependent and receptor-independent pathways.

Das T, Sa G, Paszkiewicz-Kozik E, Hilston C, Molto L, Rayman P, Kudo D, Biswas K, Bukowski RM, Finke JH, Tannenbaum CS. Das T, et al. Among authors: finke jh. J Immunol. 2008 Apr 1;180(7):4687-96. doi: 10.4049/jimmunol.180.7.4687. J Immunol. 2008. PMID: 18354192

7

GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells.

Sa G, Das T, Moon C, Hilston CM, Rayman PA, Rini BI, Tannenbaum CS, Finke JH. Sa G, et al. Among authors: finke jh. Cancer Res. 2009 Apr 1;69(7):3095-104. doi: 10.1158/0008-5472.CAN-08-3776. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276353 Free PMC article.

8

Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction.

Biswas S, Biswas K, Richmond A, Ko J, Ghosh S, Simmons M, Rayman P, Rini B, Gill I, Tannenbaum CS, Finke JH. Biswas S, et al. Among authors: finke jh. J Immunol. 2009 Oct 15;183(8):5050-8. doi: 10.4049/jimmunol.0900259. J Immunol. 2009. PMID: 19801523 Free PMC article.

9

GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway.

Mahata B, Biswas S, Rayman P, Chahlavi A, Ko J, Bhattacharjee A, Li YT, Li Y, Das T, Sa G, Raychaudhuri B, Vogelbaum MA, Tannenbaum C, Finke JH, Biswas K. Mahata B, et al. Among authors: finke jh. PLoS One. 2015 Jul 30;10(7):e0134425. doi: 10.1371/journal.pone.0134425. eCollection 2015. PLoS One. 2015. PMID: 26226135 Free PMC article.

10

Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.

Uzzo RG, Rayman P, Kolenko V, Clark PE, Bloom T, Ward AM, Molto L, Tannenbaum C, Worford LJ, Bukowski R, Tubbs R, Hsi ED, Bander NH, Novick AC, Finke JH. Uzzo RG, et al. Among authors: finke jh. Clin Cancer Res. 1999 May;5(5):1219-29. Clin Cancer Res. 1999. PMID: 10353760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

374 results

Search Page